Section 65-1660 - Dialysates, devices or drugs designated by board for treatment of persons with chronic kidney failure; inapplicability of pharmacy act; rules and regulations(a) Except as otherwise provided in this section, the provisions of the pharmacy act of the state of Kansas shall not apply to dialysates, devices or drugs which are designated by the board for the purposes of this section relating to treatment of a person with chronic kidney failure receiving dialysis and which are prescribed or ordered by a physician or a mid-level practitioner for administration or delivery to a person with chronic kidney failure if: (1) The wholesale distributor is registered with the board and lawfully holds the drug or device; and(2) the wholesale distributor: (A) Delivers the drug or device to: (i) A person with chronic kidney failure for self-administration at the person's home or specified address;(ii) a physician for administration or delivery to a person with chronic kidney failure; or(iii) a medicare approved renal dialysis facility for administering or delivering to a person with chronic kidney failure; and (B) has sufficient and qualified supervision to adequately protect the public health.(b) The wholesale distributor pursuant to subsection (a) shall be supervised by a pharmacist consultant pursuant to rules and regulations adopted by the board.(c) The board shall adopt such rules or regulations as are necessary to effectuate the provisions of this section.(d) As used in this section, "physician" means a person licensed to practice medicine and surgery; "mid-level practitioner" means mid-level practitioner as such term is defined in K.S.A. 65-1626, and amendments thereto.(e) This section shall be part of and supplemental to the pharmacy act of the state of Kansas.Amended by L. 2017, ch. 34,§ 19, eff. 4/12/2017. L. 1998, ch. 91, § 1; L. 1999, ch. 115, § 11; 4/1/2000.